These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28904510)

  • 41. Cognitive Dysfunctions Measured with the MCCB in Deficit and Non-Deficit Schizophrenia.
    Plichta P; Tyburski E; Bielecki M; Mak M; Kucharska-Mazur J; Podwalski P; Rek-Owodziń K; Waszczuk K; Sagan L; Michalczyk A; Misiak B; Samochowiec J
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive impairment profile in adolescent early-onset psychosis using the MATRICS Battery: Age and sex effects.
    Smelror RE; Johannessen C; Wedervang-Resell K; Jørgensen KN; Barth C; Andreou D; Ueland T; Andreassen OA; Myhre AM; Rund BR; Agartz I
    Neuropsychology; 2021 Mar; 35(3):300-309. PubMed ID: 33970663
    [No Abstract]   [Full Text] [Related]  

  • 43. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
    Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
    Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. General and social cognition in first episode schizophrenia: identification of separable factors and prediction of functional outcome using the IntegNeuro test battery.
    Williams LM; Whitford TJ; Flynn G; Wong W; Liddell BJ; Silverstein S; Galletly C; Harris AW; Gordon E
    Schizophr Res; 2008 Feb; 99(1-3):182-91. PubMed ID: 18053688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of cognitive functions in animal models of schizophrenia.
    Nikiforuk A
    Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints.
    Mohn C; Rund BR
    BMC Psychiatry; 2016 Apr; 16():108. PubMed ID: 27095362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.
    Mwesiga EK; Ssemata AS; Gumikiriza J; Nanteza A; Nakitende AJ; Nakku J; Akena D; Nakasujja N
    Health Qual Life Outcomes; 2022 Jul; 20(1):113. PubMed ID: 35870969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation of serum level of homocysteine and insulin resistance with cognitive dysfunction in first-episode schizophrenics].
    Liu YF; Wang YP; Zhang PF; Yuan XX; Zhu QY; Li X; Pang LJ; Li H; Song XQ
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(3):191-195. PubMed ID: 29374913
    [No Abstract]   [Full Text] [Related]  

  • 49. MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults.
    Nitzburg GC; Derosse P; Burdick KE; Peters BD; Gopin CB; Malhotra AK
    Schizophr Res; 2014 Jan; 152(1):223-8. PubMed ID: 24321710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
    Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
    Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychometric properties of the MATRICS Consensus Cognitive Battery (MCCB) in Chinese patients with major depressive disorder.
    Liang S; Yu W; Ma X; Luo S; Zhang J; Sun X; Luo X; Zhang Y
    J Affect Disord; 2020 Mar; 265():132-138. PubMed ID: 32090734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of intracortical inhibition (ICI) correlates with cognitive performance and psychopathology symptoms in schizophrenia.
    Zhu M; Xu Y; Zhang Q; Cheng X; Zhang L; Tao F; Shi J; Zhu X; Wang Z; Zhao X; Liu W
    Schizophrenia (Heidelb); 2024 Sep; 10(1):78. PubMed ID: 39277614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia.
    Yu JJ; Zhao Q; Li HN; Song JQ; Chen DC
    Aust N Z J Psychiatry; 2022 Mar; 56(3):292-300. PubMed ID: 33985351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What does the Managing Emotions branch of the MSCEIT add to the MATRICS consensus cognitive battery?
    DeTore NR; Mueser KT; McGurk SR
    Schizophr Res; 2018 Jul; 197():414-420. PubMed ID: 29486955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia.
    Wei Q; Yan W; Zhang R; Yang X; Xie S
    Ann Gen Psychiatry; 2022 Feb; 21(1):4. PubMed ID: 35144626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Fu S; Czajkowski N; Torgalsbøen AK
    Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The MATRICS consensus cognitive battery for the assessment of cognitive impairment in schizotypal personality disorder.
    Challman KN; Rosell DR; Barch D; Koenigsberg HW; Harvey PD; Hazlett EA; Perez-Rodriguez MM; New AS; McClure MM
    Schizophr Res; 2024 May; 267():308-312. PubMed ID: 38608417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.